Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12

被引:19
作者
Motl, Robert W. [1 ]
McAuley, Edward [1 ]
Mullen, Sean [1 ]
机构
[1] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA
关键词
Multiple sclerosis; Measurement; Walking; Invariance; VALIDITY; RESPONSIVENESS; FAMPRIDINE;
D O I
10.1016/j.jns.2011.03.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: One primary assumption underlying the unambiguous interpretation of change in Multiple Sclerosis Walking Scale-12 (MSWS-12) scores over time is longitudinal measurement invariance (i.e., Is the same construct being measured over time?). Such an assumption was tested in the present study over periods of 6 and 12 months in persons with relapsing-remitting multiple sclerosis (RRMS). Method: Participants completed a battery of questionnaires that included the MSWS-12 at baseline (n=269) and 6-months (n=260) and 12-months (n=252) follow-up. The data were analyzed using confirmatory factor analysis and a series of nested model comparisons in Mplus 3.0. Results: The results indicated that the unidimensional measurement model and all of its parameters (e.g., factor loadings and item intercepts) were invariant over periods of 6 and 12 months. Conclusion: We provide novel evidence that supports the unambiguous interpretation of scores from the MSWS-12 as a measure of change in walking impairment over time in a sample of persons with MS. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 20 条
[1]  
[Anonymous], INNOVATIONS
[2]   Evaluating goodness-of-fit indexes for testing measurement invariance [J].
Cheung, GW ;
Rensvold, RB .
STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL, 2002, 9 (02) :233-255
[3]  
Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117
[4]   Dose comparison trial of sustained-release fampridine in multiple sclerosis [J].
Goodman, A. D. ;
Brown, T. R. ;
Cohen, J. A. ;
Krupp, L. B. ;
Schapiro, R. ;
Schwid, S. R. ;
Cohen, R. ;
Marinucci, L. N. ;
Blight, A. R. .
NEUROLOGY, 2008, 71 (15) :1134-1141
[5]   Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial [J].
Goodman, Andrew D. ;
Brown, Theodore R. ;
Krupp, Lauren B. ;
Schapiro, Randall T. ;
Schwid, Steven R. ;
Cohen, Ron ;
Marinucci, Lawrence N. ;
Blight, Andrew R. .
LANCET, 2009, 373 (9665) :732-738
[6]   Do self-report instruments allow meaningful comparisons across diverse population groups? Testing measurement invariance using the confirmatory factor analysis framework [J].
Gregorich, Steven E. .
MEDICAL CARE, 2006, 44 (11) :S78-S94
[7]   Measuring the impact of MS on walking ability - The 12-Item MS Walking Scale (MSWS-12) [J].
Hobart, JC ;
Riazi, A ;
Lamping, DL ;
Fitzpatrick, R ;
Thompson, AJ .
NEUROLOGY, 2003, 60 (01) :31-36
[8]   A PRACTICAL AND THEORETICAL GUIDE TO MEASUREMENT INVARIANCE IN AGING RESEARCH [J].
HORN, JL ;
MCARDLE, JJ .
EXPERIMENTAL AGING RESEARCH, 1992, 18 (3-4) :117-144
[9]   Latent growth models of individual change: The case of newcomer adjustment [J].
Lance, CE ;
Vandenberg, RJ ;
Self, RM .
ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 2000, 83 (01) :107-140
[10]   Confirming the validity and responsiveness of the multiple sclerosis walking scale-12 (MSWS-12) [J].
McGuigan, C ;
Hutchinson, M .
NEUROLOGY, 2004, 62 (11) :2103-2105